Ignore This Picture
faculty photo

Mark T. Osterman, M.D., MSCE

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia
Attending Physician, Penn Medicine at Radnor, Radnor, PA
Attending Physician, Hospital of the University of Pennsylvania, Philadelphia, PA
Attending Physician, Penn Presbyterian Medical Center, Philadelphia, PA
Director, IBD Journal Club, University of Pennsylvania Perelman School of Medicine
Director, Remicade Infusion Center, Penn Medicine at Radnor, Radnor, PA
Associate Director, Inflammatory Bowel Disease Center Research, University of Pennsylvania Perelman School of Medicine
Department: Medicine

Contact information
Penn Presbyterian Medical Center
Division of Gastroenterology
218 Wright-Saunders Building
51 N 39th Street
Philadelphia, PA 19104
Office: 215-662-8900
Fax: 215-662-0950
BA (Chemistry)
Harvard University, 1995.
MD (Medicine)
Harvard Medical School, 1999.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 2005.
Post-Graduate Training
Intern in Internal Medicine, Brigham and Women's Hospital, 1999-2000.
Resident in Internal Medicine, Brigham and Women's Hospital, 2000-2002.
Fellow in Gastroenterology, University of Pennsylvania, 2002-2005.
Fellow in Clinical Epidemiology and Biostatistics, University of Pennsylvania, 2003-2005.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Osterman MT: Reply. Clinical Gastroenterology and Hepatology 13: 210-1, 2015.

Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, Chen L, Xie F, Osterman MT, Beukelman T, Margolis D, Curtis JR, Lewis JD: Risk of non-melanoma skin cancer recurrence with the use of immunomodulators and biologic agents in autoimmune disease. JAMA Dermatology 2015 Notes: In press.

Scott FI, Osterman MT: Natalizumab for Crohn’s disease: down but not out. Clin Gastroenterol Hepatol 2015 Notes: In press.

Bewtra M, Newcombe CW, Wu Q, Chen L, Xie F, Roy JA, Aarons CB, Osterman MT, Forde KA, Curtis JR, Lewis JD: Mortality Associated With Medical Therapy Versus Elective Colectomy in Ulcerative Colitis. Ann Intern Med 163: 262-70, 2015.

Vajravelu RK, Lewis JD, Osterman MT, Aberra F, Lichtenstein GR, Scott FI: Predictors of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease and Impact on Clinical Outcomes. Gastroenterology 2015 Notes: In press.

Osterman MT, Haynes K, Delzell E, Zhang J, Bewtra M, Brensinger CM, Chen L, Xie F, Curtis JR, Lewis JD: Effectiveness and Safety of Immunomodulators with Anti-TNF Therapy in Crohn's Disease. Clinical Gastroenterology and Hepatology 13: 1293-301, 2015.

Aberra FN, Osterman MT, Buchner A, Lewis JD: Can Colonoscopy Reduce the Risk of Colon Cancer and Mortality in Patients with Inflammatory Bowel Disease? Clinical Gastroenterology and Hepatology 13: 1702-3, 2015.

Henao MP, Bewtra M, Osterman MT, Aberra FN, Scott FI, Lichtenstein GR, Kraschnewski J, Lewis JD: Measurement of inflammatory bowel disease symptoms: reliability of an abbreviated approach to data collection. Inflammatory Bowel Diseases 2015 Notes: In press.

Wangensteen KJ, Fogt F, Kann BR, Osterman MT: Idiopathic Myointimal Hyperplasia of the Mesenteric Veins Diagnosed Preoperatively: Case Report and Review of the Literature. Journal of Clinical Gastroenterology 49: 491-4, 2015.

Osterman MT, Aberra FN, Cross R, Liakos S, McCabe R, Sharfan I, Wolf D, Hardi R, Nessel L, Brensinger C, Gilroy E, Lewis JD. : A randomized controlled trial of mesalamine dose escalation for ulcerative colitis in remission. Gastroenterology 146(Suppl1): S-149, 2014 Notes: Oral presentation.

back to top
Last updated: 09/24/2015
The Trustees of the University of Pennsylvania

[Return to faculty list]

University of Pennsylvania | School of Medicine